{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T11:37:21Z","timestamp":1788781041893,"version":"build-2803163510"},"reference-count":37,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2012,10,1]],"date-time":"2012-10-01T00:00:00Z","timestamp":1349049600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["European Journal of Pharmaceutical Sciences"],"published-print":{"date-parts":[[2012,10]]},"DOI":"10.1016\/j.ejps.2012.07.018","type":"journal-article","created":{"date-parts":[[2012,8,3]],"date-time":"2012-08-03T01:31:38Z","timestamp":1343957498000},"page":"596-603","source":"Crossref","is-referenced-by-count":47,"title":["Antiviral activity against the hepatitis C virus (HCV) of 1-indanone thiosemicarbazones and their inclusion complexes with hydroxypropyl-\u03b2-cyclodextrin"],"prefix":"10.1016","volume":"47","author":[{"given":"Romina J.","family":"Glisoni","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda L.","family":"Cuestas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ver\u00f3nica L.","family":"Mathet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 R.","family":"Oubi\u00f1a","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Albertina G.","family":"Moglioni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alejandro","family":"Sosnik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejps.2012.07.018_b0005","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1186\/1743-422X-8-276","article-title":"SiRNAs: potential therapeutic agents against Hepatitis C Virus","volume":"8","author":"Ashfaq","year":"2011","journal-title":"Virol. J."},{"key":"10.1016\/j.ejps.2012.07.018_b0010","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.jconrel.2007.11.004","article-title":"Preparation and in vitro evaluation of the antiviral activity of the Acyclovir complex of a \u03b2-cyclodextrin\/poly(amidoamine) copolymer","volume":"126","author":"Bencini","year":"2008","journal-title":"J. Control. Rel."},{"key":"10.1016\/j.ejps.2012.07.018_b0015","doi-asserted-by":"crossref","first-page":"13001","DOI":"10.1128\/JVI.76.24.13001-13014.2002","article-title":"Highly permissive cell lines for subgenomic and genomic hepatitis C virus RNA replication","volume":"76","author":"Blight","year":"2002","journal-title":"J. Virol."},{"key":"10.1016\/j.ejps.2012.07.018_b0020","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/j.addr.2007.05.012","article-title":"Cyclodextrins as pharmaceutical solubilizers","volume":"59","author":"Brewster","year":"2007","journal-title":"Adv. Drug Del. Rev."},{"key":"10.1016\/j.ejps.2012.07.018_b0025","doi-asserted-by":"crossref","first-page":"6818","DOI":"10.1016\/j.bmc.2011.09.037","article-title":"Thiosemicarbazones derived from 1-indanones as new anti-Trypanosoma cruzi agents","volume":"19","author":"Caputto","year":"2011","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejps.2012.07.018_b0030","doi-asserted-by":"crossref","first-page":"5436","DOI":"10.1128\/JVI.00859-10","article-title":"Inhibition of bovine viral diarrhea virus RNA synthesis by thiosemicarbazone derived from 5,6-dimethoxy-1-indanone","volume":"85","author":"Castro","year":"2011","journal-title":"J. Virol."},{"key":"10.1016\/j.ejps.2012.07.018_b0035","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1021\/mp2000132","article-title":"Poloxamines display a multiple inhibitory activity of ATP-binding cassette (ABC) transporters in cancer cell lines","volume":"8","author":"Cuestas","year":"2011","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.ejps.2012.07.018_b0040","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1007\/BF00624524","article-title":"On a new class of compounds effective in vitro against tubercle bacilli","volume":"33","author":"Domagk","year":"1946","journal-title":"Naturwissenschaften"},{"key":"10.1016\/j.ejps.2012.07.018_b0045","doi-asserted-by":"crossref","first-page":"2695","DOI":"10.1021\/jm010459j","article-title":"Synthesis and structure\u2212activity relationship study of potent trypanocidal thio semicarbazone inhibitors of the trypanosomal cysteine protease cruzain","volume":"45","author":"Du","year":"2002","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejps.2012.07.018_b0050","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.1016\/j.ejmech.2007.10.023","article-title":"New-1-indanone thiosemicarbazone derivatives active against BVDV","volume":"43","author":"Finkielsztein","year":"2008","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejps.2012.07.018_b0060","doi-asserted-by":"crossref","first-page":"2047","DOI":"10.1039\/c0nj00061b","article-title":"Self-aggregation behaviour of novel thiosemicarbazone drug candidates with potential antiviral activity","volume":"34","author":"Glisoni","year":"2010","journal-title":"New J. Chem."},{"key":"10.1016\/j.ejps.2012.07.018_b0065","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1007\/s11095-011-0599-y","article-title":"Novel 1-Indanone thiosemicarbazone antiviral candidates: aqueous solubilization and physical stabilization by means of cyclodextrins","volume":"29","author":"Glisoni","year":"2012","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ejps.2012.07.018_b0190","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1002\/cmdc.201100060","article-title":"Synthesis, Structural characterization, and pro-apoptotic activity of 1-indanone thiosemicarbazone platinum(II) and palladium(II) complexes: potential as antileukemic agents","volume":"6","author":"G\u00f3mez","year":"2011","journal-title":"ChemMedChem"},{"key":"10.1016\/j.ejps.2012.07.018_b0075","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1016\/j.fct.2005.03.007","article-title":"2-Hydroxypropyl-\u03b2-cyclodextrin (HP\u03b2-CD): a toxicology review","volume":"43","author":"Gould","year":"2005","journal-title":"Food Chem. Toxicol."},{"key":"10.1016\/j.ejps.2012.07.018_b0080","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.antiviral.2004.01.003","article-title":"Improved antiviral activity in vitro of ribavirin against measles virus after complexation with cyclodextrins","volume":"62","author":"Grancher","year":"2004","journal-title":"Antiviral Res."},{"key":"10.1016\/j.ejps.2012.07.018_b0085","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.jhep.2011.01.011","article-title":"Hepatitis C virus resistance to protease inhibitors","volume":"55","author":"Halfon","year":"2011","journal-title":"J. Hepatol."},{"key":"10.1016\/j.ejps.2012.07.018_b0070","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1080\/14756360701408614","article-title":"Synthesis and in vitro antimicrobial studies of some new 3-[phenyldiazenyl] benzaldehyde N-phenyl thiosemicarbazones","volume":"23","author":"Halve","year":"2008","journal-title":"J. Enzym. Inhib. Med. Chem."},{"key":"10.1016\/j.ejps.2012.07.018_b0090","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1002\/jbm.a.31195","article-title":"Influence of cyclodextrins on the proliferation of HaCaT keratinocytes in vitro","volume":"83","author":"Hipler","year":"2007","journal-title":"J. Biom. Mat. Res. Part A"},{"key":"10.1016\/j.ejps.2012.07.018_b0095","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1586\/eri.11.33","article-title":"Hepatitis C virus-associated insulin resistance: pathogenic mechanisms and clinical implications","volume":"9","author":"Hung","year":"2011","journal-title":"Expert Rev. Anti. Infect. Ther."},{"key":"10.1016\/j.ejps.2012.07.018_b0100","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1556\/OH.2011.29112","article-title":"New therapeutic options in chronic hepatitis C virus infection","volume":"152","author":"Hunyadi","year":"2011","journal-title":"Orv. Hetil."},{"key":"10.1016\/j.ejps.2012.07.018_b0105","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1097\/00001813-200101000-00009","article-title":"Platinum (II) and Palladium (II) complexes with 2-acetylpyridine thiosemicarbazone: cytogenetic and antineoplastic effects","volume":"12","author":"Iakovidou","year":"2001","journal-title":"Anti-Cancer Drugs"},{"key":"10.1016\/j.ejps.2012.07.018_b0110","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1556\/OH.2011.29209","article-title":"Fatty liver and hepatitis C virus infection","volume":"152","author":"Lakatos","year":"2011","journal-title":"Orv. Hetil."},{"key":"10.1016\/j.ejps.2012.07.018_b0115","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1586\/eri.11.10","article-title":"Antiviral therapy: why does it fail in HCV-related chronic hepatitis?","volume":"9","author":"Masarone","year":"2011","journal-title":"Expert Rev. Anti. Infect. Ther."},{"key":"10.1016\/j.ejps.2012.07.018_b0120","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.jconrel.2007.11.003","article-title":"In vitro toxicity and permeation of cyclodextrins in Calu-3 cells","volume":"126","author":"Matilainen","year":"2008","journal-title":"J. Control. Rel."},{"key":"10.1016\/j.ejps.2012.07.018_b0125","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.ijpharm.2009.11.035","article-title":"Self-assembled cyclodextrin aggregates and nanoparticles","volume":"387","author":"Messner","year":"2009","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejps.2012.07.018_b0130","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/BF02830587","article-title":"Triamterene-\u03b2-cyclodextrin system: preparation, characterization and in vivo evaluation","volume":"5","author":"Mukne","year":"2004","journal-title":"AAPS PharmSciTech"},{"key":"10.1016\/j.ejps.2012.07.018_b0135","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S0166-3542(01)00218-2","article-title":"In vitro antiviral efficacy of the ganciclovir complexed with beta-cyclodextrin on human cytomegalo virus clinical strains","volume":"54","author":"Nicolazzi","year":"2002","journal-title":"Antiviral Res."},{"key":"10.1016\/j.ejps.2012.07.018_b0140","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.antiviral.2004.09.002","article-title":"Enhancement of antiviral activity against hepatitis C virus in vitro by interferon combination therapy","volume":"65","author":"Okuse","year":"2005","journal-title":"Antiviral Res."},{"key":"10.1016\/j.ejps.2012.07.018_b0145","first-page":"35","article-title":"Attempts to treat chronic hepatitis C with HCV protease inhibitor","volume":"65","author":"Pawlowska","year":"2011","journal-title":"Przegl. Epidemiol."},{"key":"10.1016\/j.ejps.2012.07.018_b0150","doi-asserted-by":"crossref","first-page":"8765","DOI":"10.1021\/jm1007616","article-title":"Antiretroviral activity of thiosemicarbazone metal complexes","volume":"53","author":"Pelosi","year":"2010","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejps.2012.07.018_b0155","first-page":"S123","article-title":"Emerging therapeutic options in hepatitis C virus infection","volume":"17","author":"Poordad","year":"2011","journal-title":"Am. J. Manag. Care."},{"key":"10.1016\/j.ejps.2012.07.018_b0160","doi-asserted-by":"crossref","first-page":"2429","DOI":"10.1056\/NEJMcp1006613","article-title":"Chronic hepatitis C infection","volume":"364","author":"Rosen","year":"2011","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ejps.2012.07.018_b0165","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1016\/j.cld.2011.05.004","article-title":"Interferon-free regimens: the near future, the likely and the not so likely","volume":"15","author":"Shiffman","year":"2011","journal-title":"Clin. Liver Dis."},{"key":"10.1016\/j.ejps.2012.07.018_b0170","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1093\/jac\/dkr215","article-title":"Directly acting antivirals against hepatitis C virus","volume":"66","author":"Soriano","year":"2011","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.ejps.2012.07.018_b0175","doi-asserted-by":"crossref","first-page":"1888","DOI":"10.1016\/j.bmcl.2007.01.037","article-title":"N-Hydroxythiosemicarbazones: synthesis and in vitro antitubercular activity","volume":"17","author":"Sriram","year":"2007","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.ejps.2012.07.018_b0180","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S0378-5173(02)00523-9","article-title":"Enhanced transport of a novel anti-HIV agent-cosalane and its congeners across human intestinal epithelial (Caco-2) cell monolayers","volume":"250","author":"Udata","year":"2003","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejps.2012.07.018_b0185","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1186\/2047-783X-16-7-303","article-title":"New hepatitis C therapies in clinical development","volume":"16","author":"Vermehren","year":"2011","journal-title":"Eur. J. Med. Res."}],"container-title":["European Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0928098712002965?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0928098712002965?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,7,2]],"date-time":"2019-07-02T12:37:10Z","timestamp":1562071030000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0928098712002965"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,10]]},"references-count":37,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2012,10]]}},"alternative-id":["S0928098712002965"],"URL":"https:\/\/doi.org\/10.1016\/j.ejps.2012.07.018","relation":{},"ISSN":["0928-0987"],"issn-type":[{"value":"0928-0987","type":"print"}],"subject":[],"published":{"date-parts":[[2012,10]]}}}